Prosecution Insights
Prosecution Insights
6 pending office actions • 5 art units • 6 examiners • 0 of 6 (0%) have an AI response strategy ready • 7 patents granted in the last 365 days
Based on the USPTO statutory response window for each pending office action. 1 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §101 + other | 2 (33%) |
| §112 only | 1 (17%) |
| Double-patenting only | 1 (17%) |
| Multi-statute (no §101) | 2 (33%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| RYAN, DOUGLAS CHARLES | 1 | 40.3% | +50.7% |
| CHOWDHURY, IQBAL HOSSAIN | 1 | 73.7% | +57.4% |
| WESTON, ALYSSA G | 1 | 60.0% | +51.3% |
| HILL, MYRON G | 1 | 66.2% | +20.3% |
| MARTINEZ, TARA L | 1 | 62.7% | +65.0% |
| KELLY, ROBERT M | 1 | 73.8% | +24.8% |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 4 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18029806 | METHODS OF DETECTING ANTI-AAV ANTIBODIES | HILL, MYRON G | 14d |
| 18249418 | GENERATION OF CD4+ EFFECTOR AND REGULATORY T CELLS FROM HUMAN PLURIPOTENT STEM CELLS | WESTON, ALYSSA G | — |
| 18247093 | NOVEL ZINC FINGER PROTEIN TRANSCRIPTION FACTORS FOR REPRESSING ALPHA-SYNUCLEIN EXPRESSION | MARTINEZ, TARA L | — |
| 17766076 | Zinc Finger Protein Transcription Factors for Repressing Alpha-Synuclein Expression | KELLY, ROBERT M | — |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 6 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18029806 | METHODS OF DETECTING ANTI-AAV ANTIBODIES | HILL, MYRON G | 14d |
| 18609899 | METHODS AND COMPOSITIONS FOR THE TREATMENT OF RARE DISEASES | RYAN, DOUGLAS CHARLES | — |
| 18493366 | ENGINEERED TARGET SPECIFIC NUCLEASES | CHOWDHURY, IQBAL HOSSAIN | — |
| 18249418 | GENERATION OF CD4+ EFFECTOR AND REGULATORY T CELLS FROM HUMAN PLURIPOTENT STEM CELLS | WESTON, ALYSSA G | — |
| 18247093 | NOVEL ZINC FINGER PROTEIN TRANSCRIPTION FACTORS FOR REPRESSING ALPHA-SYNUCLEIN EXPRESSION | MARTINEZ, TARA L | — |
| 17766076 | Zinc Finger Protein Transcription Factors for Repressing Alpha-Synuclein Expression | KELLY, ROBERT M | — |
| Art Unit | Apps |
|---|---|
| 1656 | 1 |
| 1633 | 1 |
| 1671 | 1 |
| 1654 | 1 |
| 1638 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 18609899 | METHODS AND COMPOSITIONS FOR THE TREATMENT OF RARE DISEASES | RYAN, DOUGLAS CHARLES | — | DP | Non-Final OA | — | Pending | Mar 19, 2024 |
| 18493366 | ENGINEERED TARGET SPECIFIC NUCLEASES | CHOWDHURY, IQBAL HOSSAIN | 1656 | §112 | Final Rejection | — | Pending | Oct 24, 2023 |
| 18249418 | GENERATION OF CD4+ EFFECTOR AND REGULATORY T CELLS FROM HUMAN PLURIPOTENT STEM CELLS | WESTON, ALYSSA G | 1633 | §102§103§112 | Final Rejection | — | Pending | Apr 18, 2023 |
| 18029806 | METHODS OF DETECTING ANTI-AAV ANTIBODIES | HILL, MYRON G | 1671 | §101§103§112 | Non-Final OA | 14d | Pending | Mar 31, 2023 |
| 18247093 | NOVEL ZINC FINGER PROTEIN TRANSCRIPTION FACTORS FOR REPRESSING ALPHA-SYNUCLEIN EXPRESSION | MARTINEZ, TARA L | 1654 | §103§112 | Non-Final OA | — | Pending | Mar 29, 2023 |
| 17766076 | Zinc Finger Protein Transcription Factors for Repressing Alpha-Synuclein Expression | KELLY, ROBERT M | 1638 | §101§112 | Non-Final OA | — | Pending | Apr 01, 2022 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial